GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Other Stockholders Equity

TSMRF (Tsumura) Other Stockholders Equity : $233 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura Other Stockholders Equity?

Tsumura's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $233 Mil.

Tsumura's quarterly Other Stockholders Equity declined from Mar. 2024 ($157 Mil) to Jun. 2024 ($0 Mil) but then increased from Jun. 2024 ($0 Mil) to Sep. 2024 ($233 Mil).

Tsumura's annual Other Stockholders Equity declined from Mar. 2022 ($115 Mil) to Mar. 2023 ($112 Mil) but then increased from Mar. 2023 ($112 Mil) to Mar. 2024 ($157 Mil).


Tsumura Other Stockholders Equity Historical Data

The historical data trend for Tsumura's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Other Stockholders Equity Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.28 51.00 115.10 112.28 156.82

Tsumura Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152.48 168.59 156.82 - 232.75

Tsumura Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Tsumura Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tsumura's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura Headlines

From GuruFocus

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research 02-15-2024